Velarion · Company Intelligence
CompBrief
Fiscal year 2025

Paula Ragan — FY2025 total compensation $2,640,569

Paula Ragan is Former President and Chief Executive Officer of X4 Pharmaceuticals, Inc (XFOR). The company reported total compensation of $2,640,569 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$420,170
Bonus$0
Stock awards$1,081,575
Option awards$0
Non-equity incentive plan$0
Pension and non-qualified deferred compensation$0
All other compensation$1,138,824
Total$2,640,569

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure X4 Pharmaceuticals, Inc filed March 20, 2026, accession 0001501697-26-000031.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2025Former President and Chief Executive Officer$420,170$0$1,081,575$0$0$0$1,138,824$2,640,569
FY2024Former President and Chief Executive Officer$654,156$0$312,962$857,686$305,818$0$14,419$2,145,041

Totals as disclosed in each year's own compensation disclosure for X4 Pharmaceuticals, Inc.

04

The other named executive officers of X4 Pharmaceuticals, Inc

Named executive officerRoleFY2025 total
Adam CraigExecutive Chairman$6,705,205
John VolponePresident and Chief Operating Officer$6,667,487
David KirskeChief Financial Officer, Treasurer and Corporate Secretary$4,599,266
Paula Ragan this pageFormer President and Chief Executive Officer$2,640,569

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full X4 Pharmaceuticals, Inc compensation brief.

05

The company page

Paula Ragan's compensation sits inside X4 Pharmaceuticals, Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The X4 Pharmaceuticals, Inc (XFOR) compensation brief